Followers | 3180 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 14, 2019 9:02:59 AM
So over the approx. past 10 weeks with no fresh news flowing yet including the key Rotmans closing being inserted into place yet, the share price has been drifting towards the lower range of its 3 months sideways solidification phase at the established upper share price platform while the market awaits the onset of VYST's next sequence of fresh valuation driving catalysts.
VYST put out a couple of tweets recently suggesting that the FEC and Rotmans closings are both close, along with a new RxAir Distributor joint press release approaching...and tomorrow VYST's Q1 financial results are due.
So that's 4 near term catalysts that we know about, and there's also a multitude of other proprietary competitive advantage products all coming out of extensive R&D and moving into full-fledged commercialization too, and many of those products have been extensively tested with big names(some of the big names we know about/some of the big names we don't), so in a nutshell the gamble is simple from here....do people believe that VYST is on the verge of finally announcing their Rotmans acquisition closing as the company says they are?
Because the moment VYST does in fact announce Rotmans and everything that follows as they complete their transformation out of R&D and into full fledged commercialization, the new money that begins arriving here in the post Rotmans acquisition era as VYST embarks on its exchange up listing journey all summer long, will begin applying constantly evolving valuation metrics on each and every fresh valuation driving development/result VYST releases, and all they're going to care about is how dramatic the increase in VYST's value is becoming all summer long and beyond glty:)
Recent VYST News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 05:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM